Galectin Therapeutics
GALT
#8462
Rank
C$0.38 B
Marketcap
C$3.86
Share price
-4.27%
Change (1 day)
-48.87%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2026 (TTM): C-$0.65

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.67. In 2025 the company made an earnings per share (EPS) of C-$0.69 an increase over its 2024 EPS that were of C-$1.09.

EPS history for Galectin Therapeutics from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.65-4.93%
2025C-$0.69-36.84%
2024C-$1.092.7%
2023C-$1.0613.85%
2022C-$0.9325%
2021C-$0.7526.83%
2020C-$0.595.13%
2019C-$0.562.63%
2018C-$0.54-22.45%
2017C-$0.70-35.53%
2016C-$1.09-13.64%
2015C-$1.2612.82%
2014C-$1.12-40%
2013C-$1.8680.56%
2012C-$1.03-32.08%
2011C-$1.5213.98%
2010C-$1.33-22.5%
2009C-$1.72185.71%
2008C-$0.60-70.83%
2007C-$2.06118.18%
2006C-$0.95-54.17%
2005C-$2.06-14.29%
2004C-$2.4147.37%
2003C-$1.63-13.64%
2002C-$1.89-24.14%
2001C-$2.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
C-$17.52 2,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C-$0.19-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA